IAG’s Experts Attend Osteoarthritis Imaging Meeting

IAG's Experts Attend Osteoarthritis Imaging Meeting

Meet IAG’s Musculoskeletal Expert Team at ISOAI, Marrakech, Morocco, 24-26 June, 2024

24 Jun 2024 London, UK –  Image Analysis Group (IAG), a leader in imaging clinical trials, announces its focus on addressing operational challenges in musculoskeletal clinical trials, specifically osteoarthritis. As a sponsor of the upcoming annual meeting of the International Society of Osteoarthritis Imaging (ISOAI) 2024, IAG’ senior medical leadership will showcase its expertise through presentations by Prof. Boesen and Dr. Carrino, key members of IAG’s Musculoskeletal research scientific and medical team.

We are excited to announce the two keynote presentations:

26 June 2024, 9:30am – Imaging of BMLs in clinical trials, by Dr. John Carrino

26 June 2024, 11:30am – Advanced imaging of inflammation in clinical trials and novel approaches, by prof. Mikael Boesen, MD, PhD

among other outstanding speakers invited to the workshop.  Full program: https://www.isoai.org/program2024                                                        

Leveraging Dynamika™: A Cloud-Based Platform for Enhanced Efficiency

IAG recognizes the complexities associated with running effective musculoskeletal clinical trials. IAG’s innovative Dynamika™ platform tackles these challenges head-on by providing:

  • Remote Trial Management: The cloud-based platform DYNAMIKA facilitates efficient data collection and analysis, eliminating the need for additional software installation, purchase of hardware and burdening the sites or readers during global clinical trials.
  • Standardized and Objective Image Analysis: Dynamika™ utilizes advanced algorithms to ensure consistent and quantitative assessment of osteoarthritis progression, overcoming subjective bias inherent in traditional methods. Our global team of world class experts collaborated with biotech and pharma companies for over a decade.
  • Quicker Go/No-Go Decisions: Faster and more accurate data analysis enables earlier identification of treatment efficacy or futility, leading to more efficient resource allocation and reduced development timelines.
  • Improved Patient Selection / Reducing Site Burden: Dynamika™ supports the selection of ideal trial participants by providing robust and objective measures of disease severity.

Bridging the Gap Between Science and Operations

“At IAG, we understand the critical role of operational efficiency in successful clinical trials,” says  Prof. Boesen, IAG’s Sn Therapeutic Lead. “By providing objective and centralized imaging analysis, Dynamika™ empowers researchers and clinical teams to make data-driven decisions, ultimately accelerating the development of life-changing treatments for musculoskeletal diseases.”

Join IAG at ISOAI 2024, reach: imaging.experts@ia-grp.com

‘The Image Analysis Group (IAG) is a leading provider of medical imaging analysis solutions for clinical trials and research. Our mission is to empower researchers and clinicians with advanced imaging analytics to accelerate the development of new treatments.’, said Dr Kubassova, President of IAG, ‘We sponsor this event and support Prof. Guermazi on his mission to bring the best of imaging into IA drug development.

About Image Analysis Group (IAG)

Leading imaging Clinical Research Organization (iCRO) that combines medical and operational expertise with cutting-edge proprietary A.I. capabilities to power drug development, and to deliver the potential for companion diagnostic tool. IAG has been serving biotech and pharma clients globally since 2007, reliably supporting all aspects of phase I to III imaging trials across multiple indications. With a pioneering proven innovation strategy, we enhance the value and market potential of novel therapeutic assets, as demonstrated through successful pharmaceutical partnerships.

Reach out: imaging.experts@ia-grp.com

Follow the Company: Linkedin